Salt Lake City, UTNCT06902298Now EnrollingIRB Ready

Major Depressive Episode Clinical Trial in Salt Lake City, UT

Access cutting-edge major depressive episode treatment through this clinical trial at a research site in Salt Lake City. Study-provided care at no cost to qualified participants.

Sponsored by Brian Mickey

Quick Self-Assessment

See if you qualify for this Salt Lake City location

Preparing your pre-screening questions…

Expert Care in Salt Lake City

Access major depressive episode specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related major depressive episode treatment provided free

Apply for This Salt Lake City Location

Check if you qualify for this major depressive episode clinical trial in Salt Lake City, UT

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Salt Lake City

    Convenient for UT residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Salt Lake City site if eligible
  4. 4Begin participation

About This Major Depressive Episode Study in Salt Lake City

This study will evaluate a new form of non-invasive brain stimulation for individuals with depression. Personalized low-intensity transcranial focused ultrasound stimulation will be delivered using a range of stimulation parameters during psychological and physiological monitoring. Individualized optimal targets will be selected using structural MRI and diffusion tractography. Brain target engagement will be evaluated using functional MRI.

Sponsor: Brian Mickey

Who Can Participate

Inclusion Criteria

Age 18-65, any gender.
Primary diagnosis of DMS-5 major depressive disorder (MINI).
Current moderate-to-severe depressive episode, without psychotic features, lasting at least 2 months (MINI).
Self-rated 16-item Quick Inventory of Depressive Symptomatology (QIDS) total score \> 10.
History of at least 2 failed trials of evidence-based antidepressant medication and/or psychotherapy (at least one trial during the current depressive episode).
Stated willingness to comply with all study procedures and avoid changes to psychiatric treatments (medications, psychotherapy) for the duration of the study.
For participants of reproductive potential: negative pregnancy test or use of highly effective contraception for at least 1 month prior to baseline; agreement to use such a method throughout the study.
Capacity to provide informed consent; provision of a signed and dated consent form
Currently are under the care of a licensed psychiatrist or other mental health care provider, or a licensed addiction medicine specialist and agrees to promptly inform the investigator or the study staff of any change in these providers.
Agrees to allow any and all forms of communication between the investigators/study staff and any healthcare provider who currently provides and/or has provided service to the patient/subject within at least two years of study enrollment for the purposes of eligibility confirmation or in case of a safety event.
Agrees to provide the name and verifiable contact information (email and mailing addresses, mobile and land-line phone numbers, as applicable) of at least two persons 22 years or older who reside within a 60-minute drive of the patient's residence. Subject agrees that in the event of a safety concern or event during study participation, research staff is at liberty to contact these individuals if the subject does not respond to contact attempts.

Exclusion Criteria

History of serious brain injury or other neurologic disorder.
Poorly managed general medical condition.
Pregnant or breast feeding.
Implanted device in the head or neck.
MRI intolerance or contraindication.
Brain stimulation treatment such as ECT, TMS, or VNS (past month).
Recent change in antidepressant treatments (past month).
8\. Moderate-High Risk of Suicide according to the Columbia - Suicide Severity Rating Scale (C-SSRS) Screen Version - Recent (answers YES to Question 3 and NO to Question 6 (Moderate risk) or YES to Question 4, 5, or 6 (High risk)) and/or in the clinical judgement of the PI or a study psychiatrist
Suicidal behavior (past year).
Serious suicide attempt 33 (lifetime).
Moderate-to-severe substance use disorder (MINI, past 3 months).
Obsessive compulsive disorder, primary diagnosis (MINI, past month).
Posttraumatic stress disorder, primary diagnosis (MINI, past month).
Bipolar-spectrum disorder (MINI, lifetime).
Schizophrenia-spectrum disorder (MINI, lifetime).
Neurocognitive disorder (DSM-5, past year).
Severe personality disorder.
Clinically inappropriate for participation in the study as determined by the study team.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Salt Lake City?

Yes, this clinical trial (NCT06902298) has an active research site in Salt Lake City, UT that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Major Depressive Episode Treatment Options in Salt Lake City, UT

If you're searching for major depressive episode treatment options in Salt Lake City, UT, this clinical trial (NCT06902298) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Salt Lake City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced major depressive episode specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all major depressive episode clinical trials near you to find additional studies recruiting in your area.

More Depression Trials in Salt Lake City, UT

See all depression clinical trials recruiting in Salt Lake City — not just this study.

Browse Depression Trials in Salt Lake City →

Browse More Trials by Condition

Depression TrialsAll Conditions →

Ready to Join in Salt Lake City?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Salt Lake City, UT